Global Malaria Diagnostics Market Size Likely to Grow at a CAGR of 5.2% By 2035

Market Size and Growth

The malaria diagnostics market size in the world is estimated at USD 0.90 billion in 2025 and is projected to grow further by USD 0.95 billion in 2026 to about USD 1.45 billion by 2035 at a CAGR of 5.2% between 2026 and 2035.

Malaria Diagnostics Market Revenue and Trends

Malaria diagnostics in the global market comprise rapid diagnostic tests (RDTs), microscopy and molecular tests such as PCR to detect the Plasmodium parasites in the endemic areas and aid in elimination. Malaria diagnostics market is becoming increasingly competitive worldwide with the continued high rate of malaria in tropical areas, increased government and non-governmental funding in malaria control programs, the need to have point-of-care testing, and the improved sensitivity and affordable RDTs and molecular technologies in the healthcare systems across the world.

What are the Factors That Have a Significant Contribution to the Growth of the malaria diagnostics market?

The current heavy malaria burden especially in sub-Saharan Africa, where more than 90 percent of the burden is observed, and the problem of climate change, migration, and drug resistance have increased the demand for accurate and fast diagnostic products. Reports by WHO indicate that hundreds of millions of cases are still experienced every year and early diagnoses are vital in minimizing mortality. With the increased effort of global eradication efforts, prevention efforts are focused more on the mass testing of endemic regions, community health, and surveillance to prevent outbreaks.

Technological advancements have provided very sensitive RDTs, artificial intelligence-assisted microscopy, handheld PCR devices, and multiplex assays to enhance detection rates, comfort of use in distant locations and specificity. Other motivators are increased funding internationally by organisations such as the Global Fund, increased awareness of early diagnosis, better access to health care in rural settings and government sponsored screening and eradication efforts in the highly endemic as well as the low-transmission areas.

Segment Insight

By Product Type

As of 2025, rapid diagnostic tests (RDTs) occupied the greatest share of the malaria diagnostics market, driven by the need to detect and identify SARS-like antigens by products that are quicker, can be deployed in the field, and need minimum training and equipment. These tests play an essential role in the early detection of cases in the community and in managing resources in a limited setting and are highly impacted by the technological advancements in ultra-sensitive and multiplex RDT (which are widely considered by health workers crucial to scaling up testing and reaching WHO elimination targets).

By Distribution Channel

The biggest market share is occupied by the public health programs and the NGO procurement channels which are the main distribution center of bulk supplies, subsidized kits, and integrated malaria control programs. As they offer training, quality assurance, and logistical support of national programs controlling high-burden endemic regions, these channels are more preferable to governments and international organizations that need to conduct the deployment of diagnostic strategies at a large scale.

Regional Insights

The Middle East and Africa have dominated the world malaria diagnostics market with the largest disease burden, which is concentrated in sub-Saharan Africa, strong international investments, and the extensive use of RDTs to test the community. The area enjoys a good collaboration with WHO and the world funds, well-developed surveillance systems, and continuous elimination endeavors in certain countries that keep the demand and innovation going.

In the meantime, the Asia Pacific region has the greatest growth in the market of malaria diagnostics due to the high number of cases in such countries as India and Indonesia, growing elimination activities, the growing urbanization that is accompanied by a threat of transmissions, and the development of healthcare infrastructure. The adoption of advanced RDTs and molecular tools in countries in Southeast Asia is at an increased rate, facilitated by the increased national investments, public awareness, and government-sponsored malaria control interventions. Market growth in Asia Pacific is also enhanced by economic growth and integration of digital healthcare.

Report Scope

Recent Developments

• In September 2024: QIAGEN expanded its partnership with Bio-Manguinhos/Fiocruz to launch an advanced PCR-based molecular screening platform for detecting malaria alongside HIV, Hepatitis B and C in endemic regions. (Source: QIAGEN)

List of the prominent players in the Malaria Diagnostics Market:

• Abbott Laboratories
• Access Bio Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd.
• Premier Medical Corporation Pvt. Ltd.
• Sysmex Corporation
• bioMérieux SA
• Siemens Healthineers
• Others

The Malaria Diagnostics Market is segmented as follows:

By Technology

• Rapid Diagnostic Tests (RDTs)
  • Single Species Detection
  • Multi-Species Detection
• Microscopy
  • Light Microscopy
  • Fluorescence Microscopy
• Molecular Diagnostic Tests
  • Conventional PCR
  • Real-Time PCR
  • LAMP (Loop-Mediated Isothermal Amplification)
• Other Technologies

By Product Type

• Diagnostic Kits & Reagents
• Instruments
• Software & Services

By End-User

• Hospitals & Clinics
• Diagnostic Centers
• Academic & Research Institutes
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America